DJ Bristol Myers Squibb Co. Stock Outperforms Competitors Despite Losses On The Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Bristol Myers Squibb Co. $(BMY)$ slipped 1.51% to $61.46 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.19% to 7,666.45 and the Dow Jones Industrial Average rising 0.04% to 50,926.56.

This was the stock's third consecutive day of losses.

Bristol Myers Squibb Co. closed 10.46% short of its 52-week high of $68.64, which the company achieved on August 19th.

The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Johnson & Johnson $(JNJ)$ fell 2.30% to $258.66, Pfizer Inc. $(PFE)$ fell 1.40% to $28.12, and Abbott Laboratories $(ABT)$ fell 2.17% to $96.69.

Trading volume (10.7 M) remained 507,251 below its 50-day average volume of 11.2 M.

Data source: Dow Jones Market Data, FactSet. Data compiled October 1, 2026.